Author:
Kucharekova M.,Hornix M.,Ashikaga T.,T'kint S.,de Jongh G. J.,Schalkwijk J.,van de Kerkhof P. C. M.,van der Valk P. G. M.
Publisher
Springer Science and Business Media LLC
Subject
Dermatology,General Medicine
Reference30 articles.
1. Doherty AM (1999) Phosphodiesterase 4 inhibitors as novel anti-inflammatory agents. Curr Opin Chem Biol 3:466–473
2. Hanifin JM, Chan SC, Cheng JB, et al (1996) Type 4 phosphodiesterase inhibitors have clinical and in vitro anti-inflammatory effects in atopic dermatitis. J Invest Dermatol 107:51–56
3. Ferrer L, Alberola J, Queralt M, et al (1999) Clinical anti-inflammatory efficacy of arofylline, a new selective phosphodiesterase-4 inhibitor, in dogs with atopic dermatitis. Vet Rec 145:191–194
4. Griswold DE, Webb EF, Badger AM, et al (1998) SB 207499 (Ariflo), a second generation phosphodiesterase 4 inhibitor, reduces tumor necrosis factor alpha and interleukin-4 production in vivo. J Pharmacol Exp Ther 287:705–711
5. Cohan VL, Showell HJ, Fisher DA, et al (1996) In vitro pharmacology of the novel phosphodiesterase type 4 inhibitor, CP-80633. J Pharmacol Exp Ther 278:1356–1361
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献